他汀类药物辅助治疗肺炎或脓毒症疗效的Meta分析

doi:10.13481/j.1671-587x.20160228

Abstract

Abstract:

Objective: To systematically review the effects of statins in the treatment of the patients with pneumonia or sepsis, and to provide evidence-based basis for the using of statin in treatment of pneumonia or sepsis.Methods: PubMed, Embase, The Cochrane Library, CNKI, WanFang Data and VIP were searched for randomized placebo-controlled trials of statins published from the establishment time of datebases to January 31, 2015.The qualities of the included studies were independently assessed by two reviewers and the relevant data was extracted for analysis using Review Manager 5.3.Results: Nine trails involving a total of 1227 patients were included.①A total of 6 studies about the mortality of hospitalized patients were included in the Meta-analysis;compared with placebo group, statins didn't improve the mortality of hospitalized patients with pneumonia or sepsis; risk ratio (RR)=0.83, 95%CI(0.63, 1.08), P=0.17.②A total of 7 studies about the rates of mechanical ventilation usage or ICU admission of the patients were included in the Meta-analysis.Compared with placebo group, statins didn't improve the rates of mechanical ventilation usage or ICU admission of the patients with bacteria infection; RR=0.99, 95% CI(0.96, 1.03), P=0.62.③A total of 4 studies about the levels of C reaction protein (CRP) were included in the Meta-analysis.Compared with placebo group, statins significantly reduced the levels of CRP; mean differences(MD)=-8.30mg·L^-1, 95%CI(-12.13, -4.47), P<0.0001.Conclusion: Statins can not significantly reduce both the in-hospital mortality and the rates of mechanical ventilation usage or ICU admission, but can significantly reduce the plasma CRP levels, and reduce the inflammation.

Key words: statins, pneumonia, sepsis, Meta-analysis

CLC Number:

R563.1

QIU Lijie, ZHANG Ye, ZHANG Wenjing, QIAN Donghua. Meta-analysis on curative effects of statins in treatment of pneumoniaor or sepsis[J].Journal of Jilin University Medicine Edition, 2016, 42(02): 336-344.

References

[1] De Loecker I,Preiser JC.Statins in the critically ill[J].Ann Intensive Care,2012,2(1):19.

[2] Abeles AM,Pillinger MH.Statins as antiinflammatory and immunomodulatory agents:a future in rheumatologic therapy?[J].Arthritis Rheum,2006,54(2):393-407.

[3] Khan AR,Riaz M,Bin Abdulhak AA,et al.The role of statins in prevention and treatment of community acquired pneumonia:a systematic review and meta-analysis[J].PLoS One,2013,8(1):e52929.

[4] Kwok CS,Yeong JK,Turner RM,et al.Statins and associated risk of pneumonia:a systematic review and meta-analysis of observational studies[J].Eur J Clin Pharmacol,2012,68(5):747-755.

[5] Wan YD,Sun TW,Kan QC,et al.Effect of statin therapy on mortality from infection and sepsis:a meta-analysis of randomized and observational studies[J].Crit Care,2014,18:R71.

[6] 郑辉烈,王忠旭,王增珍.Meta分析中发表偏倚的Begg's检验,Egger's检验及Macaskill's检验的SAS程序实现[J].中国循证医学杂志,2009,9(8):910-916.

[7] Sterne JA,Gavaghan D,Egger M.Publication and related bias in meta-analysis:power of statistical tests and prevalence in the literature[J].J Clin Epidemiol,2000,53(11):1119-1129.

[8] Papazian L,Roch A,Charles PE,et al.Effect of statin therapy on mortality in patients with ventilator-associated pneumonia:a randomized clinical trial[J].JAMA,2013,310(16):1692-1700.

[9] 孙广信,李国燕,李振华.阿托伐他汀辅助治疗重症社区获得性肺炎的临床探索[J].中国卫生产业,2012,9(19):78.

[10] Novack V,Eisinger M,Frenkel A,et al.The effects of statin therapy on inflammatory cytokines in patients with bacterial infections:a randomized double-blind placebo controlled clinical trial[J].Intens Care Med,2009,35(7):1255-1260.

[11] Kruger PS,Harward ML,Jones MA,et al.Continuation of statin therapy in patients with presumed infection:a randomized controlled trial[J].Am J Respir Crit Care Med,2011,183(6):774-781.

[12] Viasus D,Garcia-Vidal C,Simonetti AF,et al.The effect of simvastatin on inflammatory cytokines in community-acquired pneumonia:a randomised,double-blind,placebo-controlled trial[J].BMJ Open,2015,5(1):e006251.

[13] Kruger P,Bailey M,Bellomo R,et al.A multicenter randomized trial of atorvastatin therapy in intensive care patients with severe sepsis[J].Am J Respir Crit Care Med,2013,187(7):743-750.

[14] Patel JM,Snaith C,Thickett DR,et al.Randomized double-blind placebo-controlled trial of 40 mg/day of atorvastatin in reducing the severity of sepsis in ward patients (ASEPSIS Trial)[J].Crit Care,2012,16(6):R231.

[15] Makris D,Manoulakas E,Komnos A,et al.Effect of pravastatin on the frequency of ventilator-associated pneumonia and on intensive care unit mortality:Open-label,randomized study[J].Crit Care Med,2011,39(11):2440-2446.

[16] 舒平,周慧云,黄志刚,等.阿托伐他汀对脓毒症患者急性肾损伤的保护作用[J].中华危重症医学杂志:电子版,2013,6(2):5-9.

[17] Xing XQ,Duan S,Wu XW,et al.Atorvastatin reduces lipopolysaccharide-induced expression of C-reactive protein in human lung epithelial cells[J].Mol Med Rep,2011,4(4):753-757.

[18] Iwata A,Shirai R,Ishii H,et al.Inhibitory effect of statins on inflammatory cytokine production from human bronchial epithelial cells[J].Clin Exp Immunol,2012,168(2):234-240.

[19] Troeman DP,Postma DF,van Werkhoven CH,et al.The immunomodulatory effects of statins in community-acquired pneumonia:a systematic review[J].J Infect,2013,67(2):93-101.

[20] Merx MW,Liehn EA,Graf J,et al.Statin treatment after onset of sepsis in a murine model improves survival[J].Circulation,2005,112(1):117-124.

Meta-analysis on curative effects of statins in treatment of pneumoniaor or sepsis

PDF (PC)

Like

Knowledge

Abstract

Cite this article

share this article

References

Related Articles 15

Metrics

Comments

Recommended 0

[1]	QI Lu, BAI Wei, YU Weiying, LI Yuanyuan, HUA Wanqing, KOU Changgui. Randomized controlled trials for curative effect of saxagliptin combined with insulin in treatment of patients with type 2 diabetes mellitus: Meta-analysis [J]. Journal of Jilin University(Medicine Edition), 2018, 44(06): 1235-1242.
[2]	ZHENG Guilang, GUO Yuxiong, LYU Juanjuan, HUANG Jinda, LIU Cui, ZENG Qiyi. Protective effect of overexpression of uncoupling protein 2 on mitochondria in cardiomyocytes of rats with sepsis [J]. Journal of Jilin University Medicine Edition, 2018, 44(04): 698-703.
[3]	NIU Huikun, QU Yangming, LI Meiqi, LI Lu, LYU Xin, SONG Yuanyuan, GAO Chunshi, LI Bo. Meta-analysis on efficacy and adverse effects of neoadjuvant chemotherapy combined with capecitabine in treatment of breast cancer [J]. Journal of Jilin University Medicine Edition, 2017, 43(06): 1171-1176.
[4]	YAO Yanan, YAO Hua, YAN Duoduo, LYU Kejia, GONG Lijun, WANG Guohua. Meta-analysis on correlation between oral lichen planus and Candida albicans infection [J]. Journal of Jilin University Medicine Edition, 2017, 43(05): 967-974.
[5]	NIU Meng, DENG Dayong, LI Yunpengfei, LIU Shuo, DING Jun. Values of MRE in diagnosis of stages of hepatic fibrosis:A Meta-analysis [J]. Journal of Jilin University Medicine Edition, 2017, 43(04): 787-793.
[6]	MA Ranyang, YU Hong, WANG Xin. Evaluation on clinical efficacy of hyperbaric oxygenation in treatment of sudden deafness:A Meta-analysis [J]. Journal of Jilin University Medicine Edition, 2017, 43(02): 298-305.
[7]	ZHANG Yang, WANG Junfeng, CAOHongyan, QIN Ling, XU Guoliang. Effectiveness and safety of Dengzhanhuasu and Dansheng Injection in treatment of patients with angina pectoris of coronary heart disease:A Meta-analysis [J]. Journal of Jilin University Medicine Edition, 2017, 43(02): 317-321.
[8]	XU Jin, CHEN Huaiji, XU Feng, WANG Qi, ZHANG Yuezhu, LIU Hongbo, ZHANG Tianrong, YE Lin. Association between phthalate ester exposure and population obesity:A Meta-analysis [J]. Journal of Jilin University Medicine Edition, 2017, 43(02): 306-310.
[9]	LI Wenjing, XU Meng, GUO Lishuang, YANG Siyui, LIU Jinxiang. Detection of Mycoplasma pneumoniae antibody in children with Henoch-Schonlein purpura and its clinical significance [J]. Journal of Jilin University Medicine Edition, 2017, 43(01): 155-158.
[10]	SUN Di, WANG Qi, CHEN Haiji, XU Feng, ZHANG Yuezhu, ZHANG Tianrong, LIU Hongbo, YE Lin. Changes of serum thyroid hormone levels in DEHP exposure population: A Meta-analysis [J]. Journal of Jilin University Medicine Edition, 2017, 43(01): 66-72.
[11]	ZHANG Chengshuai, PAN Cuiliu, GAO Yanan, HAN Bing, ZHANG Zhiru, LI Feng. Meta-analysis on influence of androgen receptor in living conditions of patients with triple-negative breast cancer [J]. Journal of Jilin University Medicine Edition, 2017, 43(01): 73-79.
[12]	LI Xingxing, TAN Jingjin, JIANG Shan, WAHG Ke. Role of let-7 and HMGA2 in occurrence and development of lung cancer: Meta-analysis [J]. Journal of Jilin University Medicine Edition, 2016, 42(06): 1116-1125.
[13]	SU Yingying, LIU Yingyu, ZHANG Yangyu, MA Yue, YANG Guang, YOU Yueyue, FU Yingli, KOU Changgui. Network Meta-analysis of 9 kinds of Chinese herb injections combined with transcatheter arterial chemoembolization in treatment of hepatocellular carcinoma [J]. Journal of Jilin University Medicine Edition, 2016, 42(06): 1126-1131.
[14]	DU Biao, XIE Xingxing, ZHANG Jie, FAN Xiaodong, YE Yun. Systematic review of efficacy and safety of rosuvastatin in treatment of patients with primary hyperlipidemia in China [J]. Journal of Jilin University Medicine Edition, 2016, 42(05): 968-974.
[15]	ZU Dongni, ZHAO Mingyi, DU Wei, ZHAO Weichao, JIA Shubing, YANG Jingyu, XIANG Rongwu. Meta-analysis on safety of recombinant human brain natriuretic peptide in treatment of acute decompensated heart failure [J]. Journal of Jilin University Medicine Edition, 2016, 42(04): 768-776.